(Q45139213)

English

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

scientific article published on 4 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

0 references

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

atrial fibrillation

0 references

0 references

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eugene Braunwald

3

object named as

Eugene Braunwald

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Robert P Giugliano

object named as

Robert P Giugliano

2

0 references

Elliott M Antman

12

object named as

Elliott M Antman

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Jeffrey I. Weitz

8

object named as

Jeffrey I Weitz

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Michael D. Ezekowitz

6

object named as

Michael D Ezekowitz

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

7

object named as

A John Camm

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Christian C Ruff

1

object named as

Christian T Ruff

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Naveen Deenadayalu

5

object named as

Naveen Deenadayalu

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Elaine B Hoffman

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Basil S Lewis

9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Alexander Parkhomenko

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Takeshi Yamashita

11

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

0 references

publication date

4 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

383

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

9921

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

955-962

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Edoxaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Newly identified events in the RE-LY trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The increasing incidence of anticoagulant-associated intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

New-onset atrial fibrillation and warfarin initiation: High risk periods and implications for new antithrombotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962343-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(13)62343-0

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45139213&oldid=2066781403"